Jose E. Najera, MD
Medical Oncology Physician · Ocoee, FL
Jose E. Najera, MD is a medical oncology physician with a practice address in Ocoee, Florida, and NPI 1760667851, issued on Jan 8, 2008. Check the license (Florida ME176140, as entered in NPPES) on the Florida health license search; the Medicare figures below come from public CMS files.
- Name
- Jose E. Najera
- Credential
- MD
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License numbers
- ME176140 FL
29622 OK
Self-reported in NPPES; status is on the state search - Practice location
- 9900 W Colonial Dr, Ocoee, FL 34761
- Phone
- (321) 843-7440
- Enumerated
- Jan 8, 2008
- Record last updated
- Sep 15, 2025
- Fax
- (321) 843-7497
- Medicaid ID
- 200487430A OK
- Medicare enrollment
- Enrolled (PECOS I20130806000318); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 9900 W Colonial Dr
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Alka Arora, M.DHematology & Oncology Physician1265621817
- Jeffrey Chi, M.D.Medical Oncology Physician1598143125
- Shannan Leonard, FNPAdult Health Nurse Practitioner1497194534
- Jennifer Rickerds, RDRegistered Dietitian1073435178
- Regan Rostorfer, MDHematology & Oncology Physician1790936409
- Issa Zeidan, M.D.Hospice and Palliative Medicine (Family Medicine) Physician1932491867
Verify Jose E. Najera in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersFlorida health license search
Search for license ME176140Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
2.4 times the Medicare Part D claims of the average medical oncology physician in 2024
1,702 Medicare Part D claims for 260 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 24% of claims. 252 claims were for opioids.
Most prescribed
- Hydrocodone-Acetaminophen107 claims
- Prednisone73 claims
- Abiraterone Acetate62 claims
- Ondansetron Odt61 claims
- Levothyroxine Sodium57 claims
- Dexamethasone55 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 59.5 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $2,643.60
141 payments; by number, the most common kind was food and beverage; the largest payer was Pfizer Inc. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Cancer Centers OF Southwest Oklahoma, LLCLawton, OK
- Orlando Health Medical Group IncOcoee, FL
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Medical Oncology Physician providers in Florida
There are 561 medical oncology physician records in Florida.
Other medical oncology physician records in Florida
- Mahmoud AbdelsalamGainesville, FL1912844531
- Guillermo Abesada-Terk, M.D.Stuart, FL1134313273
- Patrick Acevedo, M.D.Ocala, FL1639132269
- Howard Adler, M.D.Delray Beach, FL1427006782
- Syed Ahmed, M.D.Sebring, FL1700880697
- Asim Aijaz, MDCelebration, FL1831151695
- Geethanjali Akula, M.D.Orlando, FL1366435927
- Ahmed Al-Hazzouri, M.D.Clermont, FL1841482270
- Mohammed Al-Jumayli, M.DTampa, FL1083964878
- Mina Aleksan, MDTrinity, FL1922635432
Common questions
What is Jose E. Najera, MD's NPI number?
Jose E. Najera, MD's National Provider Identifier (NPI) is 1760667851, issued on Jan 8, 2008. An NPI identifies a provider in billing; it is not a license.
Where is Jose E. Najera, MD located?
The NPPES record lists a practice address at 9900 W Colonial Dr, Ocoee, FL, 34761. Phone: (321) 843-7440. Providers update this record themselves, so call before visiting.
How can I verify Jose E. Najera, MD's license?
NPPES lists Florida license number ME176140, as entered by the provider. Search the Florida health license search at https://mqa-internet.doh.state.fl.us/mqasearchservices/healthcareproviders. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Jose E. Najera, MD prescribe under Medicare Part D?
In 2024, Jose E. Najera, MD had 1,702 Medicare Part D claims for 260 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
What is Jose E. Najera, MD's MIPS final score?
The 2023 MIPS final score is 59.5 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.